Predictive Value of Serum Medroxyprogesterone Acetate Concentration for Response in Advanced or Recurrent Breast Cancer

By Nishimura R.   Nagao K.   Matsuda M.   Baba K.   Matsuoka Y.   Yamashita H.   Fukuda M.   Higuchi A.   Ikeda K.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1407-1412

Elsevier

Access to resources Recommend Favorite

Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines

By Ory K.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 3, 2001-08 ,pp. : 187-198

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

By Di Leo A.  

Breast Cancer Research and Treatment, Vol. 86, Iss. 3, 2004-08 ,pp. : 197-206

Springer Publishing Company

Access to resources Recommend Favorite

Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen

By Paganini-Hill A.   Clark L.J.  

Breast Cancer Research and Treatment, Vol. 64, Iss. 2, 2000-11 ,pp. : 165-176

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite